113810 — Dgenx Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩30bn
- KR₩40bn
- KR₩86bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 11,198 | 12,941 | 15,010 | 11,438 | 8,798 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 20,103 | 19,931 | 14,231 | 11,872 | 22,769 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 40,927 | 40,927 | 41,151 | 33,360 | 39,619 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 34,583 | 17,483 | 17,239 | 15,343 | 15,202 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 79,054 | 65,191 | 64,735 | 55,523 | 60,692 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 49,722 | 41,590 | 35,240 | 33,131 | 33,074 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 59,571 | 52,212 | 47,832 | 39,233 | 43,032 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 19,484 | 12,979 | 16,904 | 16,290 | 17,660 |
Total Liabilities & Shareholders' Equity | 79,054 | 65,191 | 64,735 | 55,523 | 60,692 |
Total Common Shares Outstanding |